A5320: Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
Study Location:
Baltimore
Topic:
Hepatitis and HIV
Clinicaltrials.gov Link:
N/A
IRB#:
NA_00092078
Coordinator:
Ilene Wiggins, RN (Baltimore)
Anna Wimpelberg (Washington)
Enrollment:
Closed
Trial Period:
Ongoing
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1 coinfected participants who received direct-acting antiviral (DAA) therapy for HCV infection.
Men and women ≥ 18 years old, HCV/HIV-1 coinfected who failed HCV therapy any time after HCV/DAA treatment discontinuation (non-SVR); or HCV monoinfected who failed HCV therapy any time after HCV/DAA treatment discontinuation (non-SVR); or HCV/HIV-1 coinfected participants who achieved a SVR at least 12 weeks after treatment completion; or HCV monoinfected participants who achieved a SVR as at least 12 weeks after treatment completion.
Anna Wimpelberg (Washington)
202-797-3589
awimpelberg@whitman-walker.org
Ilene Wiggins, RN (Baltimore)
410-614-2766
iwiggin1@jhmi.edu